Abiopharma

New Form EFFECT - 180 Life Sciences Corp. Filed: 2025-06-26 AccNo: 9999999995-25-002043 Size: 1 KB

New Form EFFECT - Ontrak, Inc. Filed: 2025-06-26 AccNo: 9999999995-25-002041 Size: 2 KB

New Form EFFECT - Connect Biopharma Holdings Ltd Filed: 2025-06-26 AccNo: 9999999995-25-002040 Size: 1 KB

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

FDA approve NICARDIPINE HYDROCHLORIDE

FDA approve METHADONE HYDROCHLORIDE

FDA approve FAMOTIDINE

FDA approve DOXORUBICIN HYDROCHLORIDE

FDA approve METOPROLOL SUCCINATE

FDA approve PURIFIED WATER

General Announcement: COMPLETION OF THE PROPOSED DISPOSAL OF THE REMAINING 12% EQUITY INTEREST IN TSKF

Tilray Medical veröffentlicht bahnbrechende Forschungsergebnisse zur Pharmakokinetik von THC- und CBD-Formulierungen

Tilray Medical publie une recherche pionnière sur la pharmacocinétique des formulations de THC et de CBD

Kymera Therapeutics Announces Pricing of $250 Million Public Offering

Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering